Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis

NCT01032174 · clinicaltrials.gov ↗

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Maxillary Sinusitis

Interventions

DRUG: Azithromycin SR
DRUG: Amoxiclav 1000 mg

Sponsor

Pfizer